Vivimed Labs Ltd Locks at Lower Circuit With 1.93% Loss — Sellers Queue, No Buyers in Sight

Lower Circuit Event and Unfilled Supply

The stock, trading in the BE series, hit its lower circuit at Rs 5.58, down 1.93% from the previous close, within a 2% price band. This price band is relatively narrow, indicating a modest maximum daily loss allowed by the exchange. Despite the limited band, the circuit breaker was triggered, signalling that supply overwhelmed demand to the point where the exchange floor intervened to halt further decline. The total traded volume was 0.10737 lakh shares, with a turnover of just ₹0.006 crore, underscoring the thin trading activity on the day.

On a lower circuit day, the presence of unfilled supply means sellers are queuing at the floor price but buyers are absent, effectively freezing the price. This situation is particularly acute for Vivimed Labs Ltd, a micro-cap stock with a market capitalisation of approximately ₹48 crore, where liquidity constraints amplify exit difficulties. Vivimed Labs Ltd’s circuit lock highlights the challenge sellers face in exiting positions when demand evaporates — how deep is the exit problem for this micro-cap and what would need to change for normal trading to resume?

Delivery and Volume Analysis: Genuine Selling or Speculative Shorts?

Delivery volume on 17 Sep 2026 was recorded at 100 shares, which represents a sharp decline of 98.61% against the 5-day average delivery volume. This fall in delivery volume on a lower circuit day suggests that the selling pressure may be driven more by speculative short-selling rather than genuine liquidation of holdings. In contrast to rising delivery volumes on a lower circuit, which indicate holders dumping actual shares, the falling delivery here points to a less severe capitulation scenario.

However, the total traded volume and turnover remain extremely low, which complicates interpretation. The stock’s liquidity profile is weak, with a trade size based on 2% of the 5-day average traded value effectively at zero rupees, indicating that even small trades can move the price significantly. This illiquidity can exacerbate price declines and prolong circuit locks, as sellers struggle to find buyers willing to absorb supply — does the delivery data suggest a temporary speculative move or a deeper selling pressure yet to surface?

Intraday Price Action: Narrow Range Near Circuit

The stock traded within a narrow intraday range, with a high of Rs 5.78 and a low of Rs 5.58, closing at the circuit floor. This limited price movement near the lower band indicates that the stock opened close to the circuit and remained there throughout the session, with no meaningful recovery attempt. The absence of intraday rebounds suggests that buyers were reluctant to step in at any price above the floor, reinforcing the impression of persistent selling pressure and a lack of demand.

Moving Averages and Trend Context

Vivimed Labs Ltd is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day — confirming a sustained downtrend. This technical positioning indicates that the stock has been under pressure for some time, and the lower circuit event is an acceleration of an already weak trend. The lack of support from moving averages suggests limited technical floors nearby, raising the question does the technical profile of Vivimed Labs show any nearby support, or is more downside likely?

Liquidity and Exit Risk in a Micro-Cap Context

With a market capitalisation of just ₹48 crore, Vivimed Labs Ltd falls squarely within the micro-cap segment, where liquidity constraints are a defining feature. The stock’s turnover of ₹0.006 crore on the circuit day is negligible, and the trade size based on 2% of the 5-day average traded value is effectively zero, signalling that meaningful exits are difficult to execute without impacting the price.

In such a scenario, the lower circuit acts as a double-edged sword: it limits losses but also traps sellers who cannot find buyers at any price above the floor. This illiquidity can lead to multi-day circuit locks, prolonging the period during which holders are unable to exit positions. how severe is the liquidity exit risk for Vivimed Labs and what conditions might alleviate this pressure?

Brief Fundamental Context

Vivimed Labs Ltd operates within the Pharmaceuticals & Drugs industry, a sector that can be volatile for micro-cap companies due to regulatory and market dynamics. While fundamentals are not the focus here, the micro-cap status combined with technical weakness and liquidity constraints paints a challenging picture for the stock’s near-term trading environment.

Conclusion: Severity of Selling and Liquidity Constraints

The lower circuit lock at Rs 5.58 for Vivimed Labs Ltd reflects a market where sellers are eager to exit but buyers are absent, creating unfilled supply and a frozen price. The falling delivery volume suggests speculative short-selling rather than widespread holder capitulation, but the micro-cap’s limited liquidity means that even modest selling can trigger circuit locks and heighten exit risk.

Trading below all moving averages confirms the technical weakness, while the narrow intraday range near the circuit floor indicates a lack of recovery attempts. The combination of these factors raises the question after a 1.93% single-day loss at lower circuit, is Vivimed Labs approaching oversold territory or does the selling pressure have further to run? The complete analysis weighs the data.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →